Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study

The signal pathways and treatment of cytokine storm in COVID-19

Efficacy and safety of baricitinib for the treatment of

An overview on the treatments and prevention against COVID-19

Cureus Current Use of Baricitinib in COVID-19 Treatment and Its

Use of Baricitinib in Treatment of COVID-19: A Systematic Review

Cells, Free Full-Text

IJMS, Free Full-Text

Frontiers The effects of combination-therapy of tocilizumab and

Role of baricitinib in COVID-19 patients: A systematic review and

Tocilizumab versus baricitinib in hospitalized patients with

Full article: Therapeutic safety and efficacy of triple

Tocilizumab versus baricitinib in hospitalized patients with

Post-COVID-19 interstitial lung disease presenting with profound

Frontiers Therapeutic implications of current Janus kinase

Frontiers The effects of combination-therapy of tocilizumab and